Similar articles

• [Use of a heart-lung machine for resuscitation conditions in pulmonary embolism].

  Weiss K, Sterz F, Andel H, Wozasek G, Seitelberger R. Weiss K, et al. Dtsch Med Wochenschr. 1994 Feb 25;119(8):285. Dtsch Med Wochenschr. 1994. PMID: 8112216 German. No abstract available.
• Extensive injury after use of a mechanical cardiopulmonary resuscitation device.

  Wind J, Bekkers SC, van Hooren LJ, van Heurn LW. Wind J, et al. Am J Emerg Med. 2009 Oct;27(8):1017.e1-2. doi: 10.1016/j.ajem.2008.11.018. Am J Emerg Med. 2009. PMID: 19857428
• [Comment on the contribution by Adams H.A., Hempelmann G., Beigl B., Schmitz C.S.: Specific risks in active compression-decompression in cardiopulmonary resuscitation].

  Deller A, Block G, Heuer B, Lindner KH. Deller A, et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 1997 Mar;32(3):201-2. doi: 10.1055/s-2007-995036. Anasthesiol Intensivmed Notfallmed Schmerzther. 1997. PMID: 9128758 German. No abstract available.
• Thrombolytic therapy during or after cardiopulmonary resuscitation. Efficacy and safety of a new therapeutic approach.

  Spöhr F, Böttiger BW. Spöhr F, et al. Minerva Anestesiol. 2003 May;69(5):357-64. Minerva Anestesiol. 2003. PMID: 12768167 Review.
• [Bolus injection of recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in massive pulmonary embolism complicated with heart arrest. Report of 2 cases and review of the literature].

  Moretti C, De Felice F, Mazza A, Pinneri F. Moretti C, et al. Ital Heart J Suppl. 2003 May;4(5):420-3. Ital Heart J Suppl. 2003. PMID: 12848080 Review. Italian.